X0306 4 2021-02-10 false 0001597553 Sage Therapeutics, Inc. SAGE 0001042021 JONAS JEFFREY M C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true true false false Chief Innovation Officer Stock Option (Right to Buy) 82.27 2021-02-10 4 A false 34000.00 0.00 A 2031-02-10 Common Stock 34000.00 34000.00 D The securities awarded on February 10, 2021 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 8,500 shares of common stock shall vest on the one year anniversary of February 10, 2021, with 25,500 shares vesting in 36 equal monthly installments thereafter. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jeffrey M. Jonas 2021-02-12